Advertisement

Topics

Latest "Prolysis Limited" News Stories

01:57 EDT 18th October 2017 | BioPortfolio

Here are the most relevant search results for "Prolysis Limited" found in our extensive news archives from over 250 global news sources.

More Information about Prolysis Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Prolysis Limited for you to read. Along with our medical data and news we also list Prolysis Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of Prolysis Limited Companies for you to search.

Showing "Prolysis Limited" News Articles 1–25 of 326

Relevant

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Limited (“GMS Tenshi”), providing for the private placement of up to $25.0 million of Oncobiologics’ Series A Convertible Preferred Stock (“Series A”), as well as warrants to acquire up to an ...


Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Cantor Fitzgerald 2017 Global Healthcare Conference on Wednesday, September 27, 2017 at 8:00 a.m. Eastern Time at the InterContinental New York Barclay Hotel....

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been appointed to the Board of Telix Pharmaceuticals Limited as Non-Executive Directors. Mr. McCann will also serve in the capacity of Chairman. Telix Co-Founder and CEO Christian Behrenbruch stated, ...


Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2017, will be released after market close on Monday, October 30, 2017. Quotient will host a conference call on Tuesday, October 31, 2017 at 8:30 a.m. Eastern Time to discu...

Vical Announces that its Antifungal VL-2397 is Eligible for Limited Use Indication Approval by FDA Based on a Single Phase 2 Efficacy Trial

Vical plans to initiate Phase 2 trial of VL-2397 for the treatment of invasive aspergillosis in 4Q 2017 Management to host conference call on October 3rd at 12:00 pm ET to discuss the Phase 2 trial design SAN DIEGO, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the U.S. Food and Drug Administration (FDA) has advised that Vical’s investigational ...

Probably Relevant

Jacobson Pharma Completes Issue of HK$500 Million of Convertible Notes to Dragons 615 Limited and HH InRe JP, Ltd.

HONG KONG, CHINA -- (Marketwired) -- 10/03/17 -- Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group") (HKSE: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce the completion of issue of the Convertible Notes in a principal amount of HK$500 million to two subscribers nam...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17 JERSEY, Channel Islands, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported progress on performance evaluation studies for Mo...

MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

HONG KONG, CHINA -- (Marketwired) -- 09/19/17 -- MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage...

Global Virgin Coconut Oil Market Data Survey Report 2025 [Report Updated: 31072017] Prices from USD $1500

SummaryThe global Virgin Coconut Oil market will reach xxx Million USD in 2017 with CAGR xx% from 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Average market price by SUKMajor applicationsKey manufacturers are inclu...

CannaRoyalty Announces Annual Shareholder Meeting Voting Results

OTTAWA, ONTARIO -- (Marketwired) -- 06/16/17 -- CannaRoyalty Corp. (CSE: CRZ)(CSE: CRZ.CN)(CNSX: CRZ)(OTCQX: CNNRF) ("CannaRoyalty" or the "Company") announced today the Company's voting results of its Annual Meeting of Shareholders (the "Meeting") held on June 16, 2017. At the Meeting, the shareholders elected Marc Lustig, Greg Wilson, James Young, and Rob Harris, to the Company's Board of Dir...

Ibalizumab Long-Term Safety and Efficacy Data to be Presented at IDWeek 2017 in San Diego

MONTREAL, QUEBEC -- (Marketwired) -- 09/18/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that the abstract entitled "48-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1" will be featured in an oral presentation at the IDWeek Conference to be held in San Diego, CA, from October 4 to 8, 2017. Dr. Brinda Emu, Assis...

NORTH AMERICA MICRO IRRIGATION SYSTEMS MAREKT FORECAST 20172025 [Updated: 16052017] Prices from USD $1250

1. JAIN IRRIGATION SYSTEM LIMITED JISL2. TORO COMPANY3. NETAFIM4. NAUGRA EXPORT5. TIRUPATI STRUCTURALS LIMITED6. HARSO STEELS PVT. LTD.7. APOLLO PIPES LIMITED8. KISAN GROUP OF COMPANIES9. CAPTAIN POLYPLAST LTD.10. RIVULIS IRRIGATION11. IRRIGATION WATER TECHNOLOGIES IWT12. PARAS DRIP IRRIGATION13. KSNM MARKETING14. SHARAN POLYPLAST15. LINDSAY CORPORATION16. NELSON IRRIGATION CORPORATION17. VALMONT...

CannaRoyalty Commends Favourable CSA Notice Regarding Issuers with U.S. Marijuana-Related Activities

OTTAWA, ONTARIO -- (Marketwired) -- 10/17/17 -- CannaRoyalty Corp. (CSE: CRZ)(CSE: CRZ.CN)(CNSX: CRZ)(OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), an active investor and operator in the legal cannabis industry, commented on Canadian Securities Administrators ("CSA") Staff Notice 51-352, Issuers with U.S. Marijuana-Related Activities (the "Notice"). "With this Notice, the CSA has removed unc...

LifeArc negotiates exclusive licence deal with Nemysis Limited for oral iron supplement technology

London, UK, 20 July 2017: LifeArc, the medical research charity formerly known as MRC Technology, today announced it has negotiated a licence for an oral iron supplement technology with Nemysis Limited (Nemysis). Iron oxo-hydroxide adipate tartrate (IHAT) was developed at the Medical Research Council (MRC) Human Nutrition Research Unit, whose research LifeArc supports to increase the health b...

Lifeline Biotechnologies Updates

RENO, NV -- (Marketwired) -- 06/30/17 -- Lifeline Biotechnologies, Inc. ("The Company") (OTC PINK: LLBO) updates it shareholders and provides information to the public. The Company recently transferred breast cancer detection technology to Cyrcadia, Inc. in exchange for 4,670,000 shares of Cyrcadia, Inc. common stock and a $110,000 cash and $220,000 promissory note. The additional 4,670,000 shar...

Theratechnologies Announces Completion of the Pre-License Inspection of the Ibalizumab Manufacturing Facility

MONTREAL, QUEBEC -- (Marketwired) -- 08/02/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it has been notified by its partner, TaiMed Biologics, Inc. (TaiMed), that the U.S. Food and Drug Administration (FDA) has completed the Pre-License Inspection (PLI) of the WuXi Biologics Inc. (WuXi) facility where ibalizumab will be manufactured. The inspection was carried ...

CannaRoyalty Confirms no Hurricane Impact on Investee Operations in Puerto Rico or Florida

OTTAWA, ONTARIO -- (Marketwired) -- 09/12/17 -- CannaRoyalty Corp. (CSE: CRZ)(CSE: CRZ.CN)(CNSX: CRZ)(OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), an active investor and operator in the legal cannabis industry, today confirmed that its investee companies Natural Ventures PR, LLC ("Natural Ventures") and Alternative Medical Enterprises LLC ("AltMed") have not experienced any hurricane-related...

Ownership of Zola Finance Inc. in MedReleaf Corp.

TORONTO, CANADA -- (Marketwired) -- 06/07/17 -- MedReleaf today closed its initial public offering and secondary offering (the "IPO") pursuant to the final prospectus of MedReleaf dated May 30, 2017 (the "Prospectus") and an underwriting agreement (the "Underwriting Agreement") entered into among MedReleaf and certain selling shareholders, namely Zola Finance Inc., MENA Investment Network Inc., ...

Ownership of Raymond Leach in MedReleaf Corp.

TORONTO, CANADA -- (Marketwired) -- 06/07/17 -- MedReleaf today closed its initial public offering and secondary offering (the "IPO") pursuant to the final prospectus of MedReleaf dated May 30, 2017 (the "Prospectus") and an underwriting agreement (the "Underwriting Agreement") entered into among MedReleaf and certain selling shareholders, namely Zola Finance Inc., MENA Investment Network Inc., ...

FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab

MONTREAL, CANADA -- (Marketwired) -- 06/30/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it has been notified by its partner, TaiMed Biologics, Inc., that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ibalizumab as a treatment for multidrug resistant Human Immunodeficiency Virus-1 (MDR HIV-1). If ...

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017(TM)

MONTREAL, QUEBEC -- (Marketwired) -- 10/04/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1 who completed the 24-week Phase III study (TMB-301) and continued treatment in the Expanded Access Program study (TMB-311). These data are being presented in an oral presentatio...

Genetic Technologies Announces Comprehensive Review of Strategic Alternatives

MELBOURNE, AUSTRALIA -- (Marketwired) -- 08/25/17 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for non-hereditary breast cancer, announced today that it has initiated a strategic review. The comprehensive review wi...

GLOBAL MICRO IRRIGATION SYSTEMS MARKET FORECAST 20172025 [Updated: 16052017] Prices from USD $2500

KEY FINDINGSThe Global Micro Irrigation Systems market is expected to grow from USD 3923.0 million in 2017 and estimated to grow up to USD 14867.8 million by 2025, at 18.12% CAGR during 20172025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. Rising awareness regarding the importance of irrigation system and its usefulness in waste water utilizatio...

Possibly Relevant

IntelGenx Files Final Short Form Prospectus In Connection With Offering of Convertible Unsecured Debentures

SAINT LAURENT, QUEBEC -- (Marketwired) -- 06/29/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Corporation" or "IntelGenx") is pleased to announce that it has filed a final short form prospectus (the "Prospectus") in connection with an offering (the "Offering") of a minimum of Cdn$5,000,000 and a maximum of Cdn$10,000,000 aggregate principal amount of 8% convertible uns...

Genetic Technologies Receives Nasdaq Deficiency Notice

MELBOURNE, AUSTRALIA -- (Marketwired) -- 07/21/17 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), today announced that on 20 July 2017, it received a notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, notifying the Company that its closing bid price has been below the minimum $US1.00 per share requirement for a period o...


Quick Search
Advertisement
 

News Quicklinks